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Background: Late-life sub-threshold depressive symptoms (i.e. depressive symptoms that do not meet
the criteria for a diagnosis of major depressive disorder) are associated with impaired physical health and
function, and increased risk of major depressive disorder. Magnetic resonance imaging (MRI) studies
examining late-life major depressive disorder find structural brain changes in grey and white matter.
However, the extent to which late-life sub-threshold depression is associated with similar hallmarks is
not well established.
Methods: Participants with no history of major depressive disorder were selected from the Whitehall
Imaging Sub-Study (n¼358, mean age 6975 years, 17% female). Depressive symptoms were measured
using the Centre for Epidemiological Studies Depression Scale (CES-D) at three previous Whitehall II
Study phases (2003–04, 2007–09 and 2012–13) and at the time of the MRI scan (2012–14). The re-
lationships between current and cumulative depressive symptoms and MRI brain measures were ex-
plored using Voxel-Based Morphometry (VBM) for grey matter and Tract Based Spatial Statistics (TBSS)
for white matter.
Results: Current sub-threshold depressive symptoms were associated with significant reductions in
fractional anisotropy and increases in axial and radial diffusivity. There were no significant relationships
between current depressive symptoms and grey matter measures, or cumulative depressive symptoms
and MRI measures.
Limitations: The prevalence (10%) of sub-threshold depressive symptoms means that analyses may be
underpowered to detect subtle differences in brain structure.
Conclusions: Current sub-threshold depressive symptoms are associated with changes in white matter
microstructure, indicating that even mild depressive symptoms are associated with similar MRI hall-
marks to those in major depressive disorder.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Case-control magnetic resonance imaging (MRI) studies of late-
life major depressive disorder have repeatedly documented re-
ductions in grey matter volumes in the orbitofrontal cortex,r B.V. This is an open access article
been published here: http://
ring policy for the Whitehall
rging of imaging and clinical
odelled on this and has been
set is coming closer to com-
llow the research group and
data.
llan).hippocampus, putamen and thalamus (Du et al., 2014; Sexton
et al., 2013), and reduced white matter integrity in frontal and
temporal tracts (Sexton et al., 2009; Shimony et al., 2009; Wen
et al., 2014). Furthermore, within clinical samples, there is evi-
dence to support a continuum of structural brain changes asso-
ciated with increasing severity and duration of symptoms (Bell-
McGinty et al., 2002; Nobuhara et al., 2006).
Sub-threshold depressive symptoms (i.e. depressive symptoms
that do not meet the criteria for a diagnosis of major depressive
disorder) are reported in approximately 10% of older adults in
community settings, and are associated with similar functional
and medical comorbidities to those found in major depressive
disorder (Lyness et al., 2007; Meeks et al., 2011). They are asso-
ciated with an increased risk for developing major depressive
disorder. MRI studies suggest that similar to late-life majorunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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associated with reductions in grey matter volumes and white
matter integrity (Dotson et al., 2009; Geerlings et al., 2012;
Hayakawa et al., 2013; Lamar et al., 2010; Tudorascu et al., 2014).
However, these studies vary in the approach used and the results
reported to date. If relationships between MRI measures and sub-
threshold symptoms can be replicated and confirmed, this could
have an important public health impact, suggesting that sub-
threshold depressive symptoms may warrant greater clinical
attention.
We investigated the relationship between sub-threshold de-
pressive symptoms, and MRI measures in a UK occupational-based
cohort. Current depressive symptoms were measured at the time
of the MRI scan, and long-term depressive symptoms were mea-
sured at four time points spanning a 10 year period. We hy-
pothesised that sub-threshold depressive symptoms would be
associated with the hallmarks of major depressive disorder, and
that current and cumulative depressive symptoms would be as-
sociated with reduced grey matter volumes and reduced white
matter integrity in frontal-subcortical regions.2. Methods
2.1. Participants
The sample was drawn from 534 participants recruited to take
part in the Whitehall II Imaging Sub-Study between May 2012 and
December 2014 (Filippini et al., 2014). All participants were
members of the Whitehall II Study, a prospective occupational
cohort study established in 1985 to investigate the social gradient
in health and disease (Marmot and Brunner, 2005). All civil ser-
vants aged 35–55 working in the London offices of 20 Whitehall
departments in 1985–1988 were invited to participate. The re-
sponse rate was 73% and a sample of 10,308 people (6895 men,
3413 women) was recruited. These participants were employed in
a wide variety of roles from clerical work, through to senior ad-
ministration grades (salaries ranging from d7387 to d87,620), re-
flecting a diverse social gradient as seen in the general population
(Marmot and Brunner, 2005). Extensive data were collected
through face-to-face contact with all participants at phases 1
(1985–1988), 3 (1991–1993), 5 (1997–1999), 7 (2003–2004), 9
(2007–2009) and 11 (2012–2013); intervening phases consisted of
postal questionnaires (Phases 2, 4, 6 and 8), or face-to-face contact
with a smaller proportion of the total sample (Phase 10). For the
Whitehall Imaging sub-study, based at the University of Oxford,
participants from phase 11 (2012–13) were selected at random
from the whole Whitehall cohort and were invited to take part.
Ethical approval was obtained from the University of Oxford
Central University Research Ethics Committee, and the UCL Med-
ical School Committee on the Ethics of Human Research. Informed
written consent was obtained from all participants.
2.2. Inclusion and exclusion criteria
Eligible participants reported no history of dementia or neu-
rological illness, did not display significant abnormalities on
structural MRI scans, had no history of major depressive disorder
(assessed using the Structured Clinical Interview for DSM IV mood
disorders (First et al., 2002)), did not report use of anti-depressant
or other psychotropic medication at assessments administered in
2003–2004, 2007–2009, 2012–2013 and 2012–2014 and had
complete data relating to CES-D and MRI measures.2.3. Demographics
Age, sex, education and cognitive performance were recorded
for all participants. Education was scored on a five-point scale:
(1) no qualifications, (2) O levels or equivalent, (3) A levels, college
certificate or professional qualification, (4) degree, (5) higher de-
gree (Singh-Manoux et al., 2005). Cognition was assessed at the
time of the MRI scan using the Montreal Cognitive Assessment
(MoCA, (Nasreddine et al., 2005)).
2.4. Assessment of depressive symptoms
Depressive symptoms were assessed using the Centre for Epi-
demiological Studies Depression Scale (CES-D), a clinically vali-
dated self-report questionnaire (Radloff, 1977).
Current depressive symptoms were measured at the time of the
MRI scan (2012–2014). First, CES-D score was used to dichotomise
participants into control and sub-threshold depression groups,
with a score greater than 10 used to define sub-threshold de-
pression (as in Tudorascu et al. (2014)). Second, CES-D scores were
considered as a continuous variable across all participants.
Cumulative depressive symptoms reflected scores across four
time-points: three previous Whitehall II Study phases (2003–2004,
2007–2009 and 2012–2013) and the time of the MRI scan (2012–
2014). First, the number of times participants had been classified
as displaying sub-threshold depressive symptoms was calculated.
Second, the mean CES-D score across four time-points was
examined.
2.5. Assessment of Framingham Stroke Risk Profile
Framingham Stroke Risk Profile (FSRP) was calculated for all
participants based upon the following predictors: age, systolic
blood pressure, diabetes mellitus, cigarette smoking, prior cardi-
ovascular disease, atrial fibrillation, left ventricular hypertrophy
and use of hypertensive medication (D'Agostino et al., 1994).
2.6. MRI acquisition and analysis
MRI data were acquired at the Oxford Centre for Functional MRI
of the Brain (FMRIB) using a 3-Tesla, Siemens Magnetrom Verio
scanner with 32-channel head coil. Image analysis was performed
using tools from the FMRIB Software Library (FSL, version 5.0;
http://www.fmrib.ox.ac.uk/fsl).
2.6.1. Tissue types
Partial-volume tissue segmentation was performed using the
FMRIB Automated Segmentation Tool (FAST) (Zhang et al., 2001).
Whole brain volume was obtained by summing the volumes of
grey matter, white matter and cerebrospinal fluid (CSF), and grey
matter, white matter and CSF percentages were calculated.
2.6.2. Grey matter volume
T1-weighted structural images were acquired using a three-
dimensional rapid gradient echo sequence with repetition time
2530 ms, echo time 7.37 ms, flip angle 7°, field of view 256 mm
and voxel dimensions 1.0 mm isotropic. T1-weighted images were
processed using fsl_anat (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/fsl_
anat).
Voxel-based morphometry (VBM) was carried out using FSL-
VBM (Douaud et al., 2007), an optimised VBM protocol (Good
et al., 2001) that uses FSL tools (Smith et al., 2004). Grey matter
was segmented from brain extracted structural images, before
being registered to MNI 152 standard space using non-linear re-
gistration (Andersson et al., 2007a, 2007b). These images were
averaged and flipped along the x-axis to create a left-right
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grey matter images were non-linearly registered to the study
specific template and modulated to correct for local expansion (or
contraction) due to the non-linear component of the spatial
transformation. The modulated grey matter images were then
smoothed with an isotropic Gaussian kernel with sigma of 3 mm.
2.6.3. White matter microstructure
Diffusion Tensor Imaging (DTI) scans were acquired with an
echoplanar imaging sequence (60 diffusion weighted directions,
b-value 1500 s/mm2; 5 non-diffusion weighted images, b-value
0 s/mm2, with one b0 volume acquired in the reversed phase en-
coded direction) with repetition time 8900 ms, echo time 91.2 ms,
field of view 192 mm and voxel dimensions 2.0 mm isotropic.
Corrections for head motion as well as susceptibility and eddy-
current induced distortions were performed using the FSL tool
eddy (Andersson and Sotiropoulos, 2016). This employs a gen-
erative model approach to estimate all types of distortion, coupled
with a single resampling step with spline interpolation to correct
for all distortions simultaneously. Slices were classified as outliers
and replaced if the signal was found to be more than three stan-
dard deviations from the Gaussian process predicted slice. If over
10 slices were identified as outliers within a volume, the volume
was removed. If more than five volumes were removed, than the
scan was excluded from analyses.
Voxelwise statistical analysis of fractional anisotropy (FA), axial
diffusivity (AD) and radial diffusivity (RD) data was carried out
using Tract Based Spatial Statistics (TBSS) (Smith et al., 2006), part
of FSL (Smith et al., 2004). FA maps were created by fitting a tensor
model to the raw diffusion data using DTIFit, part of FMRIB's Dif-
fusion Toolbox (http://fsl.fmrib.ox.ac.uk/fsl/fdt). This fits a diffusion
tensor model to the raw diffusion data and then brain-extracts
using BET (Smith, 2002). All participants' FA data were aligned into
a common space using FMRIB's Nonlinear Registration Tool
(FNIRT) (Andersson et al., 2007a; 2007b), which uses a b-spline
representation of the registration warp field (Rueckert et al., 1999).
Next, the mean FA image was created and thinned to create a
mean FA skeleton representing the centres of all tracts common to
the group. This method was repeated for mean diffusivity (MD),
axial diffusivity (AD) and radial diffusivity (RD).
2.7. Statistical analysis
We employed permutation-based methods for non-parametric
testing for all analyses (Winkler et al., 2014), using Randomise for
voxelwise analysis of MRI data (5000 permutations), and Permu-
tation Analysis of Linear Models (PALM) for all other analyses.
For analyses of current sub-threshold depressive symptoms,
group differences in demographic and MRI measures were as-
sessed. Next, linear associations between current CES-D score and
MRI measures were examined. For analyses of cumulative sub-
threshold depressive symptoms, linear associations between the
number of times participants had been classified as displaying
sub-threshold depressive symptoms and demographic and MRI
measures were assessed. Next, associations with the average CES-
D score over all four time-points were examined. Age, sex, edu-
cation and MoCA score were included as covariates in all analyses
examining MRI data, with significant analyses repeated with FSRP
as an additional covariate. In all voxel-wise analyses, the sig-
nificance threshold was set at po0.05 using the threshold-free
cluster enhancement option.
3. Results
Of 534 participants recruited for the Whitehall II Imaging Sub-
Study (2012–2014), 358 were included in analyses of currentdepressive symptoms, and 303 in analysis of cumulative depres-
sive symptoms (Fig. 1). Participants excluded because of missing
data were not significantly different to the included sample in age
or sex, but displayed significantly lower education levels and
MoCA scores compared with participants with full datasets (Sup-
plementary material, Table S1). Mean CES-D scores were 4.174.9
for current symptoms, and 5.174.2 for cumulative symptoms
(Supplementary material, Figs. S1 and S2 display histograms
showing the spread of CES-D scores).
3.1. Current depressive symptoms
35 participants (10%) had CES-D scores 410 at the time of the
MRI assessment (Table 1). Participants with scores 410 did not
display significant differences in age, sex, education, MoCA scores
or FSRP compared to those with scores r10. Grey matter, white
matter and CSF percentages, were not significantly different be-
tween groups, and no significant differences in grey matter vo-
lume were detected locally using FSL-VBM.
Analyses of global DTI metrics showed that sub-threshold de-
pressive symptoms were associated with lower global FA, and
higher global AD and RD. In voxel-wise analyses, 10% of all voxels
displayed a significant reduction in FA, 3% of all voxels displayed a
significant increase in AD, and 34% of all voxels displayed a sig-
nificant increase in RD. Significant voxels primarily fell within the
frontal lobe, with parietal and temporal lobes also affected (Table 2).
The localisation of significant effects is illustrated in Fig. 2, illus-
trating that significant voxels particularly fell within the corpus
callosum, and the inferior and superior longitudinal fasciculi. Re-
sults remained significant after FSRP was included as an additional
covariate in analysis of global DTI metrics (FA p¼0.020, AD
p¼0.006, RD p¼0.007) and in voxel-wise analyses (FA 10% voxels
significant, AD 2% of voxels significant, RD 35% of voxels significant).
CES-D score at the time of the MRI assessment was also ex-
amined as a continuous variable, and was not significantly asso-
ciated with age, sex, education, MoCA score, FSRP or global MRI
measures (Supplementary material, Table S2). No significant as-
sociations were detected between current CES-D score and voxel-
wise measures of grey matter volume, using FSL-VBM, or white
matter microstructure, using TBSS.
3.2. Cumulative depressive symptoms
The number of times participants had a CES-D score 410 over
four time-points was examined. 200 participants (66%) had scores
r10 at all four time-points, 64 (21%) had a score of 410 at a
single time-point, 17 (6%) had a score of 410 at two time-points,
11 (4%) had a score of 410 at three time-points, and 10 (4%) had
scores 410 at all four time-points (Supplementary material, Table
S3). There were no significant associations between the number of
times participants scored 410 on the CES-D scale and age, sex,
education or FSRP. The number of times a participant scored 410
was significantly negatively associated with the MoCA score.
The number of times participants scored 410 on the CES-D
scale was not significantly associated with the percentage of grey
matter, white matter or CSF, or global FA, AD or RD. Voxel-wise
analyses of grey matter volume, using FSL-VBM, or white matter
microstructure, using TBSS, similarly yielded no significant results.
Mean CES-D score over four time-points was examined as a
continuous variable (Supplementary material, Table S4). The mean
CES-D score was not associated with age, sex, education or FSRP,
but was significantly negatively associated with MoCA score.
Analyses of grey matter percentage and CSF percentage were not
significant, but percentage white matter was positively associated
with mean CES-D score. No significant associations were detected
between mean CES-D score and global DTI measures, or with
Fig. 1. Attrition of participants.
Table 1
Demographic and MRI measures in those with and without current depressive
symptoms.
CES-Dr10 CES-D410 Cohen’s d p
Demographics
N (%) 323 (90%) 35 (10%)
Age (years) 69.675.3 68.874.9 -0.15 0.209
Sex (N females, %) 55 (17%) 6 (17%) o0.01 0.571
Education 3.471.1 3.671.0 0.19 0.166
MoCA 27.272.3 26.773.0 -0.21 0.138
FSRP 11.478.2 10.877.0 -0.08 0.344
Depressive symptoms
Current CES-D 2.872.7 15.675.0 4.28 o0.001
Tissue types
WB (cm3) 14427126 14347161 0.06 0.365
GM (%) 38.571.9 38.472.0 0.09 0.306
WM (%) 38.871.9 38.972.1 0.06 0.382
CSF (%) 22.772.7 22.872.5 0.12 0.250
Global DTI metrics
FA 0.4870.02 0.4770.02 0.37 0.021
AD (x103) 1.0770.02 1.0870.03 0.48 0.006
RD (x103) 0.4870.03 0.4970.03 0.47 0.008
Values are mean7standard deviation. Age, sex, education and MoCA score were
included as covariates in analyses of tissue types and global DTI metrics.
Table 2
Localisation of group differences in DTI measures between CES-Dr10 and CES-
D410 groups.
No of significant voxels % of significant voxels
FA AD RD FA AD RD
Global 12,556 3331 44,144 10 3 34
Frontal 5206 2749 22,931 11 6 48
Parietal 3427 582 8808 13 2 33
Occipital 1368 0 2179 13 0 20
Temporal 2381 0 9915 10 0 42
Number and percentage of voxels significant at po0.05, after correction for mul-
tiple comparisons across space, with age, sex, education and MoCA score included
as covariates.
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In a prospective cohort sub-study of over 300 participants, we
found that current sub-threshold depressive symptoms were as-
sociated with a pattern of reduced FA and increased AD and RD,
particularly within the corpus callosum and the inferior and su-
perior longitudinal fasciculi. This indicates that even mild de-
pressive symptoms are associated with some of the same MRI
hallmarks as major depressive disorder. We did not find an asso-
ciation with cumulative CES-D scores, suggesting that sub-
threshold depressive symptoms do not have cumulative effects on
the brain. Rather, it was depressive symptoms at the time of the
MRI scan that were relevant to white matter structural changes.
This may indicate the importance of current depressive symptoms,
or late-life symptoms, since previous studies of major depressive
disorder have shown DTI measures to be associated with later age
at onset (Sexton et al., 2012b).
Our findings are consistent with studies that identified an as-
sociation between sub-threshold depressive symptoms and re-
duced white matter integrity (Dotson et al., 2009; Lamar et al.,
2010; Shimony et al., 2009; Tudorascu et al., 2014). These studies
identified altered white matter integrity in frontal regions (Dotson
et al., 2009; Lamar et al., 2010), within the anterior cingulum
bundle (Shimony et al., 2009) and with global changes in FA (Tu-
dorascu et al., 2014). A meta-analysis of DTI studies in late-life
depression found consistent reductions in white matter integrity
within the frontal lobe, corpus callosum, uncinate fasciculi and
cingulum (Wen et al., 2014). While our results do not mirror these
previous studies exactly, there is significant overlap between our
findings and previous studies of sub-threshold depressive symp-
toms and late-life depressive disorder that find altered white
matter microstructure in frontal-subcortical regions.
Based on previous literature, the most likely explanation for an
association between white matter micro-structural changes and
depressive symptoms is the presence of vascular risk factors. The
vascular depression hypothesis proposes that vascular risk factors
can predispose, precipitate or perpetuate late-onset depression
(Alexopoulos et al., 1997). Vascular risk factors, as measured by the
FSRP have been shown to correlate with DTI metrics in late-life
major depressive disorder (Allan et al., 2012). In the current study
Fig. 2. Localisation of group differences in DTI measures between CES-Dr10 and CES-D410 groups. Voxels displaying a significant reduction in FA (red), increase in AD
(yellow) and increase in RD (blue) in the sub-threshold depression group, dilated for illustrative purposes, are overlaid on a green skeleton. Age, sex, education and MoCA
scores were included as covariates. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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and differences in DTI metrics between current sub-threshold
depression and control groups remained significant after including
FSRP as an additional covariate i.e. our results do not provide ad-
ditional support for the vascular depression hypothesis. Other
factors, for example inflammatory changes may provide an alter-
native explanation for the association (Valkanova et al., 2013).
Caution is needed in the interpretation of our findings, given
that there were no significant associations between current de-
pressive symptoms and grey matter changes, in contrast with
some previous studies (Dotson et al., 2009; Geerlings et al., 2012;
Shimony et al., 2009; Tudorascu et al., 2014). Several studies
highlighted an association between sub-threshold depressive
symptoms and volume reductions in the anterior cingulate cortex
(Dotson et al., 2009; Shimony et al., 2009; Tudorascu et al., 2014).
However, reductions in grey matter volume in other regions were
only identified in single studies: orbitofrontal cortex (Dotson et al.,
2009), hippocampus (Geerlings et al., 2012), right rectal gyrus
(Shimony et al., 2009) and insula (Tudorascu et al., 2014). The
inconsistency of results in studies of sub-threshold depressive
symptoms, as well as in late-life depressive disorder (Du et al.,
2014) mean that our lack of positive findings are not surprising.
Few studies examined both grey and white matter changes in the
same study, and our findings of white matter changes without
grey matter changes are consistent with our previous study of
late-life major depressive disorder (Sexton et al., 2012a).
Given that our study included a larger sample size than many
previous studies (Dotson et al., 2009; Lamar et al., 2010; Shimony
et al., 2009), it is unlikely that our null findings are not simply an
issue of power. Rather, our results may differ from previous studies
due to differences in inclusion and exclusion criteria, and the de-
mographics of our sample. For example, in order to exclusively
examine sub-threshold depressive symptoms, we excluded parti-
cipants with a history of major depressive disorder. We also ex-
cluded participants using anti-depressant medication as this was
considered a marker of depression severity and an additional
confounding factor that could influence structural brain measures(Geerlings et al., 2012). Positive results in previous studies in
which participants with major depressive disorder were included
may be driven by structural brain changes in these participants.
The previous literature is inconsistent about the precise defini-
tions of sub-threshold depression and an important consideration in
interpreting our results is that the average CES-D score is relatively
low compared with previous studies (e.g. mean CES-D 4.1 in this
study, compared to 7.0 (Tudorascu et al., 2014)). Although the pro-
portion of participants in this sample with a CESD score 410 (10%)
mirrors expected rates of sub-threshold depressive symptoms
(Meeks et al., 2011) the relatively low burden of depressive symp-
toms overall may mean that our analyses are underpowered to de-
tect subtle differences in brain structure, contributing to some of our
null findings. Finally, the generalizability of our results may be re-
duced by a sample of participants who were predominantly white,
male and with above average educational attainment.
Despite these limitations, the strengths of our study include a
large sample size from an established cohort, identification of
depressive symptoms cross-sectionally and longitudinally, and the
MRI acquisition and analysis methods employed. Our inclusion
and exclusion criteria allowed us to be confident of exclusively
examining sub-threshold depressive symptoms.
In summary, sub-threshold depressive symptoms have been
associated with poorer functioning and physical health (Lyness
et al., 2007), similar to impairments associated with major de-
pressive disorder. In this study we found that sub-threshold de-
pressive symptoms were associated with impaired white matter
microstructure, overlapping with the hallmarks that would be
expected in major depressive disorder. We did not find any sig-
nificant associations with grey matter. Future research should
explore the optimal CES-D cut off that can reliably detect neu-
roanatomical changes associated with depressive symptoms, and
should consider whether changes in MRI brain measures may be a
predisposing factor in sub-threshold depression.
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